ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.35
Delayed Data
As of Sep 20
 -0.16 / -3.55%
Today’s Change
1.56
Today|||52-Week Range
7.25
+132.62%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close4.51
Today’s open4.51
Day’s range4.23 - 4.55
Volume4,546,006
Average volume (3 months)1,928,001
Market cap$767.3M
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+7.81%
Earnings growth (this year)-136.87%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.71%
P/E ratio4.1
Price/Sales1,838.09
Price/Book8.88

Competitors

 Today’s
change
Today’s
% change
RCKTRocket Pharmaceutica...+0.80+6.13%
NTLAIntellia Therapeutic...-0.06-0.42%
CRTXCortexyme Inc+2.99+12.46%
URGNUrogen Pharma Ltd-0.65-1.83%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$146.0K
Annual profit (last year)-$53.1M
Net profit margin-36,381.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Laurence James Neil Cooper
President
David M. Mauney
Corporate headquarters
Boston, Massachusetts

Forecasts